Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reirradiation for recurrent head and neck squamous cell carcinoma: international expert consensus recommendations endorsed by the Reirradiation Collaborative Group, the European Society for Radiotherapy and Oncology Reirradiation Focus Group, and the American Society for Radiation Oncology.

The Lancet. Oncology·2026
Same author

Efficacy of cetuximab-based regimens after immune checkpoint inhibitor failure in recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and meta-analysis.

Oral oncology·2026
Same author

Prediction of clinical outcomes of advanced cutaneous squamous cell carcinoma to PD-1 inhibition directly from histopathology slides using inferred transcriptomics.

Frontiers in immunology·2026
Same author

Metabolic Endotoxemia Amplifies Estrogen Signaling Through Stromal Crosstalk in Obesity-Associated Breast Cancer.

International journal of molecular sciences·2026
Same author

Axillary Metastases following Total Laryngectomy: An Underrecognized Pathway.

The Journal of laryngology and otology·2026
Same author

Dental Rehabilitation of the Scapular Tip in Maxillary Reconstruction.

Head & neck·2026

Related Experiment Video

Updated: Jun 29, 2025

Surgical Treatment of an Endolymphatic Sac Tumor
04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

657

Post-radiation middle ear effusion in NPC patients: Analysis of patient, tumour, and radiation factors.

Igor Vainer1,2, Sharon Tzelnick1,2, Noga Kurman2,3

  • 1Department of Otolaryngology Head and Neck Surgery, Rabin Medical Center, Petah Tikva, Israel.

Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery
|April 4, 2024
PubMed
Summary
This summary is machine-generated.

Post-irradiation middle ear effusion (MEE) is common in nasopharyngeal carcinoma (NPC) patients. This study found no association between MEE and tumor factors or radiation doses.

Keywords:
effusionlevator veli palatinimiddle earnasopharyngeal carcinomaradiation

More Related Videos

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

10.6K
Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment
04:35

Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment

Published on: December 27, 2024

338

Related Experiment Videos

Last Updated: Jun 29, 2025

Surgical Treatment of an Endolymphatic Sac Tumor
04:34

Surgical Treatment of an Endolymphatic Sac Tumor

Published on: May 26, 2023

657
A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

10.6K
Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment
04:35

Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment

Published on: December 27, 2024

338

Area of Science:

  • Otolaryngology
  • Radiation Oncology
  • Oncology

Background:

  • Nasopharyngeal carcinoma (NPC) treatment often involves radiation therapy.
  • Middle ear effusion (MEE) is a known complication following radiation for NPC.
  • Understanding factors associated with MEE is crucial for patient management.

Purpose of the Study:

  • To investigate the association between patient, tumor, and radiation therapy factors and the development of MEE in NPC patients.
  • To identify potential risk factors for MEE after nasopharyngeal carcinoma treatment.

Main Methods:

  • Retrospective review of 73 NPC patients treated between 2000 and 2018.
  • Collected data included patient demographics, tumor characteristics, and radiation therapy details (doses and fields).
  • Analyzed and compared factors between patients with and without MEE, and between unilateral MEE sides.

Main Results:

  • 19.2% of patients presented with MEE; 18 additional patients developed MEE post-radiation.
  • Tumor stage, histology, and laterality were not associated with MEE development.
  • Radiation doses to target volumes, middle ear, eustachian tube (ET), and associated muscles (TVP, LVP) showed no significant association with MEE.

Conclusions:

  • Post-irradiation MEE is a frequent adverse event in NPC patients.
  • Contrary to expectations, tumor characteristics (stage, histology, laterality) did not correlate with MEE.
  • Radiation dose parameters, including to the middle ear and ET structures, were not linked to MEE development.